Conventional Versus Convenience: Clinician Collected or At-Home Collected Testing for Sexually Transmitted Infections

Sexually transmitted infections (STIs) have been spiking in recent years. [1]

To help slow the spread of STIs, it’s important to test early in the instance of a possible exposure, even before the appearance of any signs and symptoms. Early and accurate testing can also help reduce the risks of causing complications for the patient.

As with most public health strategies, there isn’t just one answer as to how STI testing should be implemented. For example, at-home sample collection can increase accessibility to testing, while healthcare provider (HCP) sample collection can ensure consistency. 

Read our latest white paper to learn more about both conventional and convenient approaches in STI testing. 

  • - Select -
  • Canada
  • United States
  • Please Select
  • CEO / COO / President
  • Department Head
  • Director
  • Educator
  • Lab Manager
  • Medical Doctor
  • Principal Investigator
  • Post-doctoral fellow
  • Purchaser / Procurer
  • Research Assistant / Lab Technician
  • Scientist / Associate Scientist
  • Student / Graduate
  • Vice President
  • Other
I would like to receive a quote on Thermo Fisher Scientific’s STI testing solutions.

I would like to receive information about events, products, services and promotions from Thermo Fisher Scientific and its affiliates:

 

By following relevant data privacy laws, Thermo Fisher Scientific will take great care in processing my personal data in line with its privacy policy, which can be reviewed at thermofisher.com/privacypolicy.

I can choose to unsubscribe at any time by e-mailing reply@thermofisher.com

Reference:
 

1. Centers for Disease Control and Prevention. “Sexually Transmitted Infections Prevalence, Incidence, and Cost Estimates in the United States.” Centers for Disease Control and Prevention, 25 Jan. 2021, www.cdc.gov/std/statistics/prevalence-2020-at-a-glance.htm.